IRF2 and hepatocellular carcinoma: This was validated with fluorescence-activated cell sorting (FACS) on isolated immune cells from β-M-pT3/β-M-IRF2 mouse HCC which demonstrated significant increases in total CD4+ cells with decreases in T regulatory populations in the β-M-IRF2 group (Figure S16d, S17a).